´ç´¢º´ °ü·Ã Á¶»çº¸°í¼¿¡¼´Â ´ç´¢º´ °ü·Ã Á¦Ç° ½ÃÀåÀÇ Ãֽе¿Çâ¿¡ ´ëÇØ Æø³Ð°Ô ´Ù·ç¾ú½À´Ï´Ù. ¶ÇÇÑ Ä¡·á¹ý°ú Àν¶¸°, Àν¶¸° Àü´Þ ½Ã½ºÅÛ, ¿ªÇÐÀû »óȲ, ȯÀÚ Àα¸ ¹× ¿¬·É ±¸Á¶, À¯º´ÀÚ¼ö, °Ë»ç ¹æ¹ý µî¿¡ °üÇÑ »ó¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. °¢±¹ ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ Àü¸Á¿¡ °üÇÑ º¸°í¼µµ ´Ù¼ö ±¸ºñÇϰí ÀÖ½À´Ï´Ù.
![]() |
¼¼°èÀÇ Ç×´ç´¢º´Á¦ ½ÃÀå ±Ô¸ð Á¶»ç : Á¾·ùº°(¾ËÆÄ ±Û·çÄڽôپÆÁ¦ ¾ïÁ¦Á¦, ¹ÙÀ̱¸¾Æ´Ïµå, DPP-IV ¾ïÁ¦Á¦, GLP-1 ÀÛ¿ëÁ¦ ¹× Àν¶¸°), Áúȯº°, ȯÀÚº°, ¿¹Ãø(-2025³â) - COVID-19ÀÇ ´©Àû ¿µÇâ
Antidiabetic Drug Market Research Report by Type (Alpha-glucosidase Inhibitors, Biguanides, DPP-IV Inhibitors, GLP-1 Agonists, and Insulin), by Disease, by Patient - Global Forecast to 2025 - Cumulative Impact of COVID-19
¹ßÇà 2021³â 02¿ù
°¡°Ý
US $ 3,949
![]() |
![]() |
Àν¶¸°Ææ ½ÃÀå : ÀλçÀÌÆ®, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(-2025³â)
Diabetes Pen Market Market Insights, Competitive Landscape and Market Forecast-2025
¹ßÇà 2021³â 01¿ù
°¡°Ý
US $ 4,750
![]() |
![]() |
Àν¶¸° Ç×´ç´¢º´Á¦ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¿¹Ãø(2021-2027³â)
Insulin Antidiabetics Market with COVID-19 Impact Analysis, By Type, By Drug Class, By Patient Population, By Route of Administration and By Region - Size, Share, & Forecast from 2021-2027
¹ßÇà 2021³â 01¿ù
°¡°Ý
US $ 3,250
![]() |
![]() |
´ç´¢¸Á¸·º´Áõ ½ÃÀå : Á¾·ù, ±â¼ú, Áö¿ªº° - ½ÃÀå ±Ô¸ð, Á¡À¯À², ¿¹Ãø, COVID-19ÀÇ ¿µÇ⠺м®(2021-2027³â)
Diabetic Retinopathy Market with COVID-19 Impact Analysis, By Type, By Technique, and By Region - Size, Share, & Forecast from 2021-2027
¹ßÇà 2021³â 01¿ù
°¡°Ý
US $ 3,250
![]() |
![]() |
Àΰ£ Àν¶¸° ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¿¹Ãø(2021-2027³â)
Human Insulin Market with COVID-19 Impact Analysis, By Product Type, By Delivery Devices and By Region - Size, Share, & Forecast from 2021-2027
¹ßÇà 2021³â 01¿ù
°¡°Ý
US $ 3,250
![]() |
![]() |
¼¼°èÀÇ Àΰ£ Àν¶¸° ½ÃÀå ¿¹Ãø, °æÀï µ¿Çâ, ¼ºÀå ±âȸ(-2025³â) : ÀûÀÀÁõ, ºê·£µå, Åõ¿© °æ·Î, Á¾·ù, ÀÛ¿ë ¹ßÇö ½Ã°£, Á¦Ç°, Áö¿ªº°
Global Human Insulin Market, By Indication, By Brand, By Route of Administration, By Type, By Onset Time, By Products, By Region, Forecast & Opportunities, 2025
¹ßÇà 2021³â 01¿ù
°¡°Ý
US $ 4,450
![]() |
![]() |
Áúȯ ºÐ¼® : 2Çü ´ç´¢º´
Disease Analysis: Type 2 Diabetes
¹ßÇà 2020³â 12¿ù
°¡°Ý
US $ 22,000
![]() |
![]() |
´ç´¢º´¼º ¸»ÃʽŰ溴Áõ : ÆÄÀÌÇÁ¶óÀÎ ¸®ºä
Diabetic Neuropathy - Pipeline Review, H2 2020
¹ßÇà 2020³â 11¿ù
°¡°Ý
US $ 2,000
![]() |
![]() |
´ç´¢º´¼º ½ÅÀåÁúȯ : ½ÃÀå ºÐ¼®°ú ¿¹Ãø(-2037³â)
Diabetic Nephropathy Market and Forecast Analysis to 2037
¹ßÇà 2020³â 11¿ù
°¡°Ý
US $ 22,000
![]() |
![]() |
´ç´¢º´¼º ¸Á¸·Áõ : ½ÃÀå ÀλçÀÌÆ®, ¿ªÇÐ, ½ÃÀå ¿¹Ãø(2030³â)
Diabetic Retinopathy - Market Insights, Epidemiology, and Market Forecast-2030
¹ßÇà 2020³â 11¿ù
°¡°Ý
US $ 6,950
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´¼º Á·ºÎ±Ë¾ç Ä¡·áÁ¦ ½ÃÀå(2020-2024³â)
Global Diabetic Foot Ulcers Therapeutics Market 2020-2024
¹ßÇà 2020³â 11¿ù
°¡°Ý
US $ 2,500
![]() |
![]() |
Áúȯ ºÐ¼® : 1Çü ´ç´¢º´
Disease Analysis: Type 1 Diabetes
¹ßÇà 2020³â 11¿ù
°¡°Ý
US $ 22,000
![]() |
![]() |
2Çü ´ç´¢º´ : ÁÖ¿ä 9°³±¹ ÀǾàǰ ½ÃÀå ¿¹Ãø°ú ºÐ¼®(-2029³â)
Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029
¹ßÇà 2020³â 10¿ù
°¡°Ý
US $ 10,995
![]() |
![]() |
´ç´¢º´¼º Ȳ¹ÝÁõ : ¿ªÇÐ ÀλçÀÌÆ®(-2030³â)
Diabetic Macular Disease - Epidemiology Insight - 2030
¹ßÇà 2020³â 10¿ù
°¡°Ý
US $ 3,750
![]() |
![]() |
´ç´¢º´¼º Ȳ¹ÝÁõ : ½ÃÀå ÀλçÀÌÆ®, ¿ªÇÐ, ½ÃÀå ¿¹Ãø(-2030³â)
Diabetic Macular Disease - Market Insight, Epidemiology and Market Forecast - 2030
¹ßÇà 2020³â 10¿ù
°¡°Ý
US $ 6,950
![]() |
![]() |
¼¼°èÀÇ Àν¶¸° ¿ø·áÀǾàǰ(API) ½ÃÀå : Àü¹® Á¶»ç ¸®Æ÷Æ®(2020³â)
Global Insulin API Market Professional Survey Report 2020
¹ßÇà 2020³â 10¿ù
°¡°Ý
US $ 5,000
![]() |
![]() |
¼¼°èÀÇ °æ±¸ ´ç´¢º´ Ä¡·áÁ¦ ½ÃÀå(2020-2027³â)
Global Oral Anti Diabetes Drugs Market - 2020-2027
¹ßÇà 2020³â 10¿ù
°¡°Ý
US $ 3,750
![]() |
![]() |
ÀӽŴ索 : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2020³â ÇϹݱâ)
Gestational Diabetes Disease - Global Clinical Trials Review, H2, 2020
¹ßÇà 2020³â 10¿ù
°¡°Ý
US $ 2,500
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´¼º ½Å°æº´Áõ ½ÃÀå(2020-2027³â)
Global Diabetic Neuropathy Market - 2020-2027
¹ßÇà 2020³â 09¿ù
°¡°Ý
US $ 3,750
![]() |
![]() |
Áõ½Ä¼º ´ç´¢º´¼º ¸Á¸·Áõ(PDR) : ÆÄÀÌÇÁ¶óÀÎ ¸®ºä
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2020
¹ßÇà 2020³â 09¿ù
°¡°Ý
US $ 2,000
![]() |
![]() |
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´ç´¢º´ Ä¡·á ±â±â ½ÃÀå ÀλçÀÌÆ®(MedTech 360 ¸®Æ÷Æ®)
Diabetes Care Devices | MedTech 360 | Market Insights | Asia Pacific
¹ßÇà 2020³â 09¿ù
°¡°Ý
¹®ÀÇ
|
![]() |
¼¼°èÀÇ Àν¶¸° Àü´Þ ½Ã½ºÅÛ ½ÃÀå
Insulin Delivery Systems
¹ßÇà 2020³â 09¿ù
°¡°Ý
US $ 5,450
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´ Áø´Ü ½ÃÀå
Diabetes Diagnostics
¹ßÇà 2020³â 09¿ù
°¡°Ý
US $ 5,600
![]() |
![]() |
´ç´¢¸Á¸·º´Áõ : ¿ªÇÐ ¿¹Ãø(-2029³â)
Diabetic Retinopathy - Epidemiology Forecast to 2029
¹ßÇà 2020³â 08¿ù
°¡°Ý
US $ 3,995
![]() |
![]() |
°íÇ÷´çÁõ : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä
Hyperglycemia Global Clinical Trials Review, H2, 2020
¹ßÇà 2020³â 08¿ù
°¡°Ý
US $ 2,500
![]() |